{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:01:46Z","timestamp":1790283706394,"version":"4.1.0"},"reference-count":162,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017559","name":"Recordati Rare Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017559","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Cushing syndrome (CS) and mild autonomous cortisol secretion syndrome (MACS) are states of endogenous hypercortisolemia, associated with multiple metabolic complications. The data on the impact of cortisol on the liver are inconsistent at times. From one perspective, some studies proved hepatotoxic cortisol action. Elevated liver enzymes and liver steatosis are common findings in patients with newly diagnosed CS and MACS (liver steatosis prevalence: 20%\u201366% and 25%\u201357%, respectively). Normocortisolemic subjects with liver steatosis\/metabolic-associated steatohepatitis seem to have higher cortisol concentration than the healthy population. In contrast, other studies suggest that the liver impairment prevalence in hypercortisolemic patients with so many metabolic comorbidities would be expected to be much higher than it is reported. They postulate anti-inflammatory cortisol action as a preventive factor for liver disease progression in subjects with CS and MACS. The data on the hepatic safety profile of hypercortisolemia pharmacotherapy seems to be conflicting at times. Antihypercortisolemic medical therapy can potentially cause liver impairment; therefore, implementing the treatment of hypercortisolemia is often challenging in patients with liver dysfunction. We present two CS cases with baseline liver impairment, which improved on the treatment with steroidogenesis inhibitors. The case reports are followed by literature review regarding liver dysfunction in endogenous hypercortisolemia, impact of hypothalamic\u2013pituitary\u2013adrenal axis on the liver, and liver safety profile of medical treatment used in endogenous hypercortisolemia.<\/jats:p>","DOI":"10.3389\/fendo.2025.1660316","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T04:14:11Z","timestamp":1761279251000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Liver impairment and medical management of Cushing syndrome and MACS"],"prefix":"10.3389","volume":"16","author":[{"given":"Mari","family":"Minasyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiktoria","family":"Suchy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Fedak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Gamrat-\u017bmuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicja","family":"Hubalewska-Dydejczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Valassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Gilis-Januszewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ecl.2018.01.001","article-title":"Morbidity of Cushing's syndrome and impact of treatment","volume":"47","author":"Webb","year":"2018","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing's disease: a guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(16)00086-3","article-title":"Complications of Cushing's syndrome: state of the art","volume":"4","author":"Pivonello","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.11305","article-title":"Cushing syndrome: A review","volume":"330","author":"Reincke","year":"2023","journal-title":"JAMA"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-023-00868-7","article-title":"An individualized approach to the management of Cushing disease","volume":"19","author":"Fleseriu","year":"2023","journal-title":"Nat Rev Endocrinol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/cen.15194","article-title":"Prevalence and predictive features of CT-derived nonalcoholic fatty liver disease in metabolically healthy MACS","volume":"102","author":"Candemir","year":"2025","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-024-04043-4","article-title":"Impact of cortisol on liver fat and metabolic health in adrenal incidentalomas and Cushing's syndrome","volume":"87","author":"Yu","year":"2025","journal-title":"Endocrine"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/6637396","article-title":"MAFLD in patients with Cushing's disease is negatively associated with low free thyroxine levels rather than with cortisol or TSH levels","volume":"2023","author":"Chen","year":"2023","journal-title":"Int J Endocrinol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvab048.196","article-title":"The improvement in hepatic steatosis after Cushing\u2019s syndrome treatment is an early sign of metabolic recovery","volume":"5","author":"Hamimi","year":"2021","journal-title":"J Endocr Soc"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1490543","article-title":"Hepatic steatosis in Cushing's syndrome: a radiological assessment using computed tomography","volume":"149","author":"Rockall","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7159696","article-title":"Demographic characteristics, etiology, and comorbidities of patients with Cushing's syndrome: A 10-year retrospective study at a large general hospital in China","volume":"2019","author":"Zhou","year":"2019","journal-title":"Int J Endocrinol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae568","article-title":"Fatty liver disease along Cushing's syndrome evolution","volume":"110","author":"Marengo","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1530\/endoabs.90.ep794","article-title":"MAFLD prevalence in a cohort of patients with Cushing\u2019s disease","author":"Remon","year":"2023","journal-title":"Endocr Abstracts"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i40.6735","article-title":"Pathogenesis of hepatic steatosis: the link between hypercortisolism and non-alcoholic fatty liver disease","volume":"19","author":"Tarantino","year":"2013","journal-title":"World J Gastroenterol"},{"key":"B15","unstructured":"ClinicalTrials.gov identifier: NCT05881005\n          Pr\u00e9valence de la St\u00e9ato-fibrose H\u00e9patique Dans Le Syndrome De Cushing"},{"key":"B16","unstructured":"ClinicalTrials.gov ID NCT05911620\n          Evaluation of the Severity of Hepatic Fibrosis by Magnetic Resonance Elastography in the Diagnosis of Endogenous Hypercorticism (HEPACORT)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.5603\/EP.a2023.0041","article-title":"COVID-19 infection in a patient with Cushing's disease on osilodrostat treatment","volume":"74","author":"Bogus\u0142awska","year":"2023","journal-title":"Endokrynol Pol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2023.100780","article-title":"Prognostic utility of Fibrosis-4 Index for risk of subsequent liver and cardiovascular events, and all-cause mortality in individuals with obesity and\/or type 2 diabetes: a longitudinal cohort study","volume":"36","author":"Anstee","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M116.752311","article-title":"Glucocorticoid receptor \u03b2 Induces hepatic steatosis by augmenting inflammation and inhibition of the peroxisome proliferator-activated receptor (PPAR) \u03b1","volume":"291","author":"Marino","year":"2016","journal-title":"J Biol Chem"},{"key":"B20","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1210\/me.2014-1062","article-title":"Minireview: new molecular mediators of glucocorticoid receptor activity in metabolic tissues","volume":"28","author":"Patel","year":"2014","journal-title":"Mol Endocrinol"},{"key":"B21","volume-title":"Miricorilant reduced liver Fat and Cardiometabolic Disease Markers in a Phase 1b, Open-Label Dose-Finding Study in Patients with Non-Alcoholic Steatohepatitis","author":"Alkhouri","year":""},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.176012","article-title":"Glucocorticoid receptor modulator CORT125385 alleviates diet-induced hepatosteatosis in male and female mice","volume":"957","author":"Kroon","year":"2023","journal-title":"Eur J Pharmacol"},{"key":"B23","unstructured":"ClinicalTrials.gov. A Phase 2b, Study Evaluating Miricorilant in Adult Patients with Nonalcoholic Steatohepatitis\/ Metabolic Dysfunction-Associated Steatohepatitis (MONARCH)"},{"key":"B24","volume-title":"A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients with Presumed Nonalcoholic Steatohepatitis (NCT03823703)","author":"Alkhouri","year":""},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001470","article-title":"Effect of miricorilant, a selective glucocorticoid receptor modulator, on olanzapine-associated weight gain in healthy subjects: A proof-of-concept study","volume":"41","author":"Hunt","year":"2021","journal-title":"J Clin Psychopharmacol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e79724","DOI":"10.1371\/journal.pone.0079724","article-title":"Mifepristone promotes adiponectin production and improves insulin sensitivity in a mouse model of diet-induced-obesity","volume":"8","author":"Hashimoto","year":"2013","journal-title":"PloS One"},{"key":"B27","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3109\/15376516.2015.1118715","article-title":"Thirty-day rat toxicity study reveals reversible liver toxicity of mifepristone (RU486) and metapristone","volume":"26","author":"Xiao","year":"2016","journal-title":"Toxicol Mech Methods"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s13679-024-00556-1","article-title":"Role of glucocorticoids in metabolic dysfunction-associated steatotic liver disease","volume":"13","author":"Polyzos","year":"2024","journal-title":"Curr Obes Rep"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4344905","article-title":"Glucocorticosteroids and the risk of NAFLD in inflammatory bowel disease","volume":"2022","author":"Jarmakiewicz-Czaja","year":"2022","journal-title":"Can J Gastroenterol Hepatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S247379","article-title":"Glucocorticoid-induced fatty liver disease","volume":"13","author":"Rahimi","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.5603\/ep.99689","article-title":"Metabolic-associated fatty liver disease and the role of hormones in its aetiopathogenesis","volume":"75","author":"Suwa\u0142a","year":"2024","journal-title":"Endokrynol Pol"},{"key":"B32","unstructured":"Metyrapone\n          \n          2022"},{"key":"B33","unstructured":"Metyrapone\n          \n          2024"},{"key":"B34","unstructured":"FDA adverse event reporting system"},{"key":"B35","unstructured":"Drug Induced Liver Injury Rank (DILIrank) Dataset"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1210\/jcemcr\/luad101","article-title":"Successful management of Cushing syndrome from ectopic ACTH secretion in an adolescent with osilodrostat","volume":"1","author":"Blew","year":"2023","journal-title":"JCEM Case Rep"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.4158\/EP09243.CR","article-title":"Unusual cause of ectopic secretion of adrenocorticotropic hormone: Cushing syndrome attributable to small cell prostate cancer","volume":"16","author":"Alshaikh","year":"2010","journal-title":"Endocr Pract"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1062729","article-title":"Fatal pneumocystis jirovecii pneumonia in a case of ectopic Cushing's syndrome due to neuroendocrine carcinoma of the kidney","volume":"116","author":"Arlt","year":"2008","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e52929","DOI":"10.7759\/cureus.52929","article-title":"A rare case of adrenocortical carcinoma manifesting as a pulmonary embolism","volume":"16","author":"Barnaba Durairaj","year":"2024","journal-title":"Cureus"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvaa167","article-title":"Adrenal Cushing syndrome diagnosed during pregnancy: successful medical management with metyrapone","volume":"5","author":"Azzola","year":"2020","journal-title":"J Endocr Soc"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.4158\/EP11391.CR","article-title":"Successful long-term treatment of Cushing disease with mifepristone (RU486)","volume":"18","author":"Basina","year":"2012","journal-title":"Endocr Pract"},{"key":"B42","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.aace.2021.10.004","article-title":"Cushing disease treated successfully with metyrapone during pregnancy","volume":"8","author":"Bass","year":"2021","journal-title":"AACE Clin Case Rep"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1981.tb00638.x","article-title":"Prolonged remission in florid Cushing's syndrome following metyrapone treatment","volume":"14","author":"Beardwell","year":"1981","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/BF03344091","article-title":"Cushing's syndrome during pregnancy secondary to adrenal adenoma: metyrapone treatment and laparoscopic adrenalectomy","volume":"29","author":"Blanco","year":"2006","journal-title":"J Endocrinol Invest"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.65.766.575","article-title":"Use of adrenal arterial embolization in severe ACTH-dependent Cushing's syndrome","volume":"65","author":"Blunt","year":"1989","journal-title":"Postgrad Med J"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2010.521268","article-title":"Successful outcome of pregnancy in a patient with Cushing's disease under treatment with ketoconazole during the first trimester of gestation","volume":"27","author":"Boronat","year":"2011","journal-title":"Gynecol Endocrinol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.4.5998.678","article-title":"The immunological hazard of Cushing's syndrome","volume":"4","author":"Britton","year":"1975","journal-title":"Br Med J"},{"key":"B48","doi-asserted-by":"publisher","first-page":"150115","DOI":"10.1530\/EDM-15-0115","article-title":"Fluconazole in the treatment of Cushing's disease","volume":"2016","author":"Burns","year":"2016","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/3196283","article-title":"Ectopic Cushing's syndrome unveiling a metastatic parotid carcinoma","volume":"2019","author":"Castro Oliveira","year":"2019","journal-title":"Case Rep Endocrinol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1992.tb01461.x","article-title":"Failure of somatostatin analogue to control Cushing's syndrome in two cases of ACTH-producing carcinoid tumours","volume":"36","author":"Cheung","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1993.tb02380.x","article-title":"ACTH-independent Cushing's syndrome in pregnancy with spontaneous resolution after delivery: control of the hypercortisolism with metyrapone","volume":"39","author":"Close","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1080\/09513590903015411","article-title":"Ectopic Cushing's syndrome due to a pheochromocytoma: a new case in the post-partum and review of literature","volume":"25","author":"Cohade","year":"2009","journal-title":"Gynecol Endocrinol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1985.tb03037.x","article-title":"Pregnancy complicated by Cushing's syndrome: potential hazard of metyrapone therapy","volume":"92","author":"Connell","year":"1985","journal-title":"Case Rep Br J Obstet Gynaecol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ando.2020.11.002","article-title":"Pneumocystis pneumonia can complicate medical treatment of hypercortisolism even in outpatients with Cushing's disease","volume":"81","author":"Cristante","year":"2020","journal-title":"Ann Endocrinol (Paris)"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afy102","article-title":"Behaviour disorder caused by Cushing's syndrome in an older person","volume":"47","author":"Damanti","year":"2018","journal-title":"Age Ageing"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/283458","article-title":"A pregnant woman who underwent laparoscopic adrenalectomy due to Cushing's syndrome","volume":"2014","author":"Diri","year":"2014","journal-title":"Case Rep Endocrinol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.k10e-265","article-title":"Clinical features and management of ectopic ACTH syndrome at a single institute in Japan","volume":"57","author":"Doi","year":"2010","journal-title":"Endocr J"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.62.730.727","article-title":"Successful control of Cushing's disease in the elderly with long term metyrapone","volume":"62","author":"Donckier","year":"1986","journal-title":"Postgrad Med J"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1530\/EC-17-0081","article-title":"Severe Cushing's syndrome due to small cell prostate carcinoma: a case and review of literature","volume":"6","author":"Elston","year":"2017","journal-title":"Endocr Connect"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-50-6-1062","article-title":"Pituitary carcinoma mimics the ectopic adrenocorticotropin syndrome","volume":"50","author":"Fachnie","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"B61","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1530\/EDM-21-0038","article-title":"Rapid control of ectopic Cushing's syndrome during the COVID-19 pandemic in a patient with chronic hypokalaemia","volume":"2021","author":"Faisal","year":"2021","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-6-108","article-title":"Ectopic Cushing' syndrome caused by a neuroendocrine carcinoma of the mesentery","volume":"6","author":"Fasshauer","year":"2006","journal-title":"BMC Cancer"},{"key":"B63","doi-asserted-by":"publisher","first-page":"e18160","DOI":"10.7759\/cureus.18160","article-title":"Cushing syndrome as a manifestation of neuroendocrine prostate cancer: A rare presentation within a rare tumor","volume":"13","author":"Fernandes","year":"2021","journal-title":"Cureus"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1186\/1752-1947-5-405","article-title":"Failure of functional imaging with gallium-68-DOTA-D-Phe1-Tyr3-octreotide positron emission tomography to localize the site of ectopic adrenocorticotropic hormone secretion: a case report","volume":"5","author":"Gani","year":"2011","journal-title":"J Med Case Rep"},{"key":"B65","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/s0140-6736(84)90631-7","article-title":"Sodium valproate and metyrapone for pituitary-dependent Cushing's disease","volume":"2","author":"Glaser","year":"1984","journal-title":"Lancet"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1982.tb00718.x","article-title":"Cushing's syndrome in pregnancy\u2013treatment with metyrapone","volume":"16","author":"Gormley","year":"1982","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2001.01055.x","article-title":"Recurrent ACTH-independent Cushing's syndrome in multiple pregnancies and its treatment with metyrapone","volume":"54","author":"H\u00e1na","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.66.777.584","article-title":"Metyrapone-induced alopecia","volume":"66","author":"Harries-Jones","year":"1990","journal-title":"Postgrad Med J"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.4103\/1450-1147.144823","article-title":"Gallium-68 DOTA-TATE positron emission tomography\/computed tomography: scintigraphic changes of adrenal glands following management of ectopic Cushing's syndrome by steroidogenesis inhibitors","volume":"13","author":"Huang","year":"2014","journal-title":"World J Nucl Med"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1210\/jcemcr\/luad128","article-title":"A rare case of placental abruption and postpartum compression fractures in pregnancy with Cushing syndrome","volume":"1","author":"Iioka","year":"2023","journal-title":"JCEM Case Rep"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.7.1246","article-title":"Metyrapone for Cushing's syndrome","volume":"159","author":"Inagaki","year":"2002","journal-title":"Am J Psychiatry"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-73-4-752","article-title":"Elevated plasma adrenocorticotropin (ACTH) with adrenal hyperplasia: a new factor in ACTH regulation","volume":"73","author":"Ismail","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"B73","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12902-018-0246-2","article-title":"Spontaneous adrenocorticotropic hormone (ACTH) normalisation due to tumour regression induced by metyrapone in a patient with ectopic ACTH syndrome: case report and literature review","volume":"18","author":"Iwayama","year":"2018","journal-title":"BMC Endocr Disord"},{"key":"B74","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/ncpendmet0985","article-title":"A patient with ectopic cortisol production derived from Malignant testicular masses","volume":"4","author":"Jain","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"B75","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1530\/acta.0.0930495","article-title":"Cushing's syndrome due to unilateral nodular adrenal hyperplasia: a new pathophysiological entity","volume":"93","author":"Josse","year":"1980","journal-title":"Acta Endocrinol (Copenh)"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.52.675","article-title":"Olfactory neuroblastoma causing ectopic ACTH syndrome","volume":"52","author":"Kanno","year":"2005","journal-title":"Endocr J"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2000.tb13348.x","article-title":"Pregnancy-dependent Cushing's syndrome in three pregnancies","volume":"107","author":"Kasperlik-Zaluska","year":"2000","journal-title":"BJOG"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2042.2006.01710.x","article-title":"Cushing syndrome associated with prostatic tumor adrenocorticotropic hormone (ACTH) expression after maximal androgen blockade therapy","volume":"14","author":"Kataoka","year":"2007","journal-title":"Int J Urol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1530\/acta.0.0910303","article-title":"Cushing's syndrome due to adrenocortical carcinoma - a comphrensive clinical and biochemical study of patients treated by surgery and chemotherapy","volume":"91","author":"Kelly","year":"1979","journal-title":"Acta Endocrinol (Copenh)"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1530\/acta.0.0890461","article-title":"ACTH and cortisol response to bromocriptine, and results of long-term therapy, in Cushing's disease","volume":"89","author":"Kennedy","year":"1978","journal-title":"Acta Endocrinol (Copenh)"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1210\/jcemcr\/luae015","article-title":"Prolonged hypokalemia following metyrapone treatment for primary bilateral macronodular adrenal cortical disease","volume":"2","author":"Kidawara","year":"2024","journal-title":"JCEM Case Rep"},{"key":"B82","doi-asserted-by":"publisher","first-page":"67, 71","DOI":"10.1016\/S0033-3182(85)72906-4","article-title":"Metyrapone for depression and delirium secondary to Cushing's syndrome","volume":"26","author":"Kramlinger","year":"1985","journal-title":"Psychosomatics"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejogrb.2012.12.015","article-title":"The medical management of Cushing's syndrome during pregnancy","volume":"168","author":"Lim","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(88)90116-7","article-title":"Ectopic ACTH syndrome caused by a bronchial carcinoid tumor responsive to dexamethasone, metyrapone, and corticotropin-releasing factor","volume":"84","author":"Malchoff","year":"1988","journal-title":"Am J Med"},{"key":"B85","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1002\/ajh.21519","article-title":"Profound neutropenia resulting from metyrapone-induced adrenal crisis","volume":"84","author":"Mangan","year":"2009","journal-title":"Am J Hematol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"e2011","DOI":"10.1097\/MD.0000000000002011","article-title":"Dilated cardiomyopathy revealing Cushing disease: A case report and literature review","volume":"94","author":"Marchand","year":"2015","journal-title":"Med (Baltimore)"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19800901)46:5<1263::aid-cncr2820460530>3.0.co;2-z","article-title":"Successful therapy of an ACTH-producing gastric carcinoid APUD tumor: report of a case and review of the literature","volume":"46","author":"Marcus","year":"1980","journal-title":"Cancer"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1979.tb128985.x","article-title":"Metastatic medullary carcinoma of the thyroid complicated by Cushing's syndrome","volume":"1","author":"McElduff","year":"1979","journal-title":"Med J Aust"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1996.682504.x","article-title":"ACTH independent Cushing's syndrome occurring in siblings","volume":"44","author":"Minami","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1176\/jnp.2008.20.1.113","article-title":"Reduction in salivary cortisol concentration correlates with resolution of psychosis in Cushing's syndrome","volume":"20","author":"Myhill","year":"2008","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1177\/20420188211030160","article-title":"A case of adrenal Cushing's syndrome and primary hyperparathyroidism due to an atypical parathyroid adenoma","volume":"12","author":"Newman","year":"2021","journal-title":"Ther Adv Endocrinol Metab"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1988.tb03668.x","article-title":"The combined use of sodium valproate and metyrapone in the treatment of Cushing's syndrome","volume":"28","author":"Nussey","year":"1988","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2042.2008.01995.x","article-title":"Preoperative management of Cushing's syndrome with metyrapone for severe psychiatric disturbances","volume":"15","author":"Obinata","year":"2008","journal-title":"Int J Urol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.k05-154","article-title":"Preclinical Cushing's disease characterized by massive adrenal hyperplasia and hormonal changes after three years of metyrapone therapy","volume":"54","author":"Ohmori","year":"2007","journal-title":"Endocr J"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1111\/ggi.12027","article-title":"Case report: Beneficial effect of 11\u03b2-hydroxylase inhibitor in the management of an elderly patient with an androgen-producing inoperable adrenal tumor","volume":"13","author":"Ozawa","year":"2013","journal-title":"Geriatr Gerontol Int"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2018.11.018","article-title":"Peripheral primitive neuroectodermal tumor associated with paraneoplastic Cushing's syndrome: The rare case","volume":"37","author":"Rahbar","year":"2018","journal-title":"Ann Med Surg (Lond)"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6823-14-70","article-title":"Evolution in functionality of a metastatic pancreatic neuroendocrine tumour (pNET) causing Cushing's syndrome: treatment response with chemotherapy","volume":"14","author":"Rajeev","year":"2014","journal-title":"BMC Endocr Disord"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00296","article-title":"Obstetric and neonatal outcome of pregnancy in carney complex: A case report","volume":"11","author":"Ralser","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1007\/BF03401310","article-title":"Pulmonary arterial sampling was useful for localizing ectopic ACTH production in a patient with bronchial carcinoid causing Cushing syndrome","volume":"12","author":"Sakuma","year":"2013","journal-title":"Hormones (Athens)"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1210\/jcemcr\/luae008","article-title":"A case of an ectopic ACTH-producing tumor with adrenal shrinkage during osilodrostat administration","volume":"2","author":"Sawabe","year":"2024","journal-title":"JCEM Case Rep"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-012-9228-5","article-title":"Recurrent acute-onset Cushing's syndrome 6 years after removal of a thymic neuroendocrine carcinoma: from ectopic ACTH to CRH","volume":"24","author":"Schalin-J\u00e4ntti","year":"2013","journal-title":"Endocr Pathol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3109\/01443615.2011.584645","article-title":"Type 2 diabetes identified in pregnancy secondary to Cushing's syndrome","volume":"31","author":"Schiemer","year":"2011","journal-title":"J Obstet Gynaecol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-47-2-410","article-title":"Pituitary function after removal of pituitary microadenomas in Cushing's disease","volume":"47","author":"Schnall","year":"1978","journal-title":"J Clin Endocrinol Metab"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-02268","article-title":"ACTH-dependent cyclic Cushing syndrome triggered by glucocorticoid excess through a positive-feedback mechanism","volume":"104","author":"Seki","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.aace.2022.09.003","article-title":"Recurrent Cushing syndrome from metastatic adrenocortical carcinoma with fumarate hydratase allelic variant","volume":"8","author":"Silverman","year":"2022","journal-title":"AACE Clin Case Rep"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-27-9-1285","article-title":"Cushing's syndrome in association with a carcinoid tumor of the lung","volume":"27","author":"Steel","year":"1967","journal-title":"J Clin Endocrinol Metab"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/782068","article-title":"Metyrapone for long-term medical management of Cushing's syndrome","volume":"2013","author":"Traina","year":"2013","journal-title":"Case Rep Endocrinol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"bvab 055","DOI":"10.1210\/jendso\/bvab055","article-title":"Tumor shrinkage by metyrapone in Cushing disease exhibiting glucocorticoid-induced positive feedback","volume":"5","author":"Tsujimoto","year":"2021","journal-title":"J Endocr Soc"},{"key":"B109","doi-asserted-by":"publisher","first-page":"bcr","DOI":"10.1136\/bcr-2018-227068","article-title":"Hypokalaemic metabolic alkalosis, hypertension and diabetes: what is the link","volume":"12","author":"V\u00f6gelin","year":"2019","journal-title":"BMJ Case Rep"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.85.12.7047","article-title":"Cushing's syndrome due to phaeochromocytoma secreting the precursors of adrenocorticotropin","volume":"85","author":"White","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1210\/jcemcr\/luac008","article-title":"Long-term treatment with metyrapone in a man with ectopic Cushing syndrome","volume":"2022","author":"Wong","year":"2022","journal-title":"JCEM Case Rep"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1135016","article-title":"Severe ectopic Cushing syndrome in a transgender man with a metastatic gastrinoma and an adrenal tumor-A case report and review of the literature","volume":"14","author":"Wydra","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.36.536","article-title":"Adrenocorticotropin-independent macronodular adrenocortical hyperplasia associated with multiple colon adenomas\/carcinomas which showed a point mutation in the APC gene","volume":"36","author":"Yamakita","year":"1997","journal-title":"Intern Med"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00375","article-title":"Multiple salivary cortisol measurements are a useful tool to optimize metyrapone treatment in patients with Cushing's syndromes treatment: case presentations","volume":"8","author":"Yoshida","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B115","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1530\/EDM-20-0011","article-title":"A rare cause of severe Cushing's syndrome","volume":"2020","author":"Zaman","year":"2020","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2017.1290070","article-title":"A successful case of pregnancy in a woman with ACTH-independent Cushing's syndrome treated with ketoconazole and metyrapone","volume":"33","author":"Zieleniewski","year":"2017","journal-title":"Gynecol Endocrinol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00554","article-title":"Practical considerations for the management of Cushing's disease and COVID-19: A case report","author":"Beretta","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1177\/1179551419825832","article-title":"Adrenocorticotropic hormone-dependent Cushing syndrome caused by an olfactory neuroblastoma","volume":"12","author":"Familiar","year":"2019","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"key":"B119","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1530\/EDM-20-0207","article-title":"Metastatic medullary thyroid carcinoma presenting as ectopic Cushing's syndrome","volume":"2021","author":"Forde","year":"2021","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1177\/0300060517754026","article-title":"Ectopic adrenocorticotropic hormone syndrome associated with olfactory neuroblastoma: acquirement of adrenocorticotropic hormone expression during disease course as shown by serial immunohistochemistry examinations","volume":"46","author":"Kadoya","year":"2018","journal-title":"J Int Med Res"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-013-0090-1","article-title":"Periodic hypokalemia associated with cyclic Cushing's syndrome","volume":"3","author":"Kikuchi","year":"2014","journal-title":"CEN Case Rep"},{"key":"B122","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12902-022-01090-8","article-title":"Ectopic ACTH-producing neuroendocrine tumor occurring with large recurrent metastatic pheochromocytoma: a case report","volume":"22","author":"Saishouji","year":"2022","journal-title":"BMC Endocr Disord"},{"key":"B123","first-page":"78","article-title":"Atypical thymic carcinoid associated with Cushing's syndrome","volume":"35","author":"Sato","year":"2010","journal-title":"Tokai J Exp Clin Med"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ20-0613","article-title":"Successful management of a patient with active Cushing's disease complicated with coronavirus disease 2019 (COVID-19) pneumonia","volume":"68","author":"Yuno","year":"2021","journal-title":"Endocr J"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.4158\/EP.10.2.119","article-title":"Ectopic Cushing's syndrome caused by an esthesioneuroblastoma","volume":"10","author":"Yu","year":"2004","journal-title":"Endocr Pract"},{"key":"B126","doi-asserted-by":"publisher","first-page":"150051","DOI":"10.1530\/EDM-15-0051","article-title":"Cushing's storm secondary to a rare case of ectopic ACTH secreting metastatic breast cancer","volume":"2015","author":"Bucciarelli","year":"2015","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"B127","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1186\/s12884-020-03117-1","article-title":"Pregnancy induced Cushing's syndrome and primary aldosteronism: a case report","volume":"20","author":"Kersten","year":"2020","journal-title":"BMC Pregnancy Childbirth"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6583467","article-title":"Ectopic ACTH syndrome emerging 5 years after the diagnosis of neuroendocrine tumor","volume":"2019","author":"Liu","year":"2019","journal-title":"Case Rep Endocrinol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"bcr2017223406","DOI":"10.1136\/bcr-2017-223406","article-title":"Hypertension and severe hypokalaemia associated with ectopic ACTH production","volume":"2018","author":"Lobo Ferreira","year":"2018","journal-title":"BMJ Case Rep"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1016\/j.aace.2024.01.007","article-title":"Cushing syndrome due to a corticotropin-releasing hormone- and adrenocorticotropic hormone-secreting silent pheochromocytoma","volume":"10","author":"Moctezuma","year":"2024","journal-title":"AACE Clin Case Rep"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-11-0949","article-title":"Prolonged remission after long-term treatment with steroidogenesis inhibitors in Cushing's syndrome caused by ectopic ACTH secretion","volume":"166","author":"Sharma","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.48.665","article-title":"Rational, effective metyrapone treatment of ACTH-independent bilateral macronodular adrenocortical hyperplasia (AIMAH)","volume":"48","author":"Omori","year":"2001","journal-title":"Endocr J"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.4158\/ACCR-2018-0429","article-title":"ECTOPIC adrenocorticotropic hormone syndrome due to metastatic prostate cancer with neuroendocrine differentiation","volume":"5","author":"Soundarrajan","year":"2019","journal-title":"AACE Clin Case Rep"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1002\/iju5.12637","article-title":"Cushing's syndrome in pregnancy in which laparoscopic adrenalectomy was safely performed by a retroperitoneal approach","volume":"6","author":"Takeuchi","year":"2023","journal-title":"IJU Case Rep"},{"key":"B135","doi-asserted-by":"publisher","first-page":"bcr2013009974","DOI":"10.1136\/bcr-2013-009974","article-title":"Cardio-respiratory failure secondary to ectopic Cushing's syndrome as the index presentation of small-cell lung cancer","volume":"2013","author":"von Stempel","year":"2013","journal-title":"BMJ Case Rep"},{"key":"B136","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1479-828X.2011.01388.x","article-title":"Pregnancy-induced Cushing's syndrome in recurrent pregnancies: case report and literature review","volume":"52","author":"Achong","year":"2012","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13718","article-title":"Unexpected adverse effect of metyrapone: A case report","volume":"89","author":"Rouland","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B138","unstructured":"Isturisa\n          \n          2024"},{"key":"B139","unstructured":"Ketoconazole 200 mg\n          \n          2014"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(19)30313-4","article-title":"Efficacy and safety of levoketoconazole in the treatment of endogenous Cushing's syndrome (SONICS): a phase 3, multicentre, open-label, single-arm trial","volume":"7","author":"Fleseriu","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-18-0694","article-title":"Should we avoid using ketoconazole in patients with severe Cushing\u2019s syndrome and increased levels of liver enzymes","volume":"179","author":"Ollivier","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"B142","unstructured":"Observational Registry on Patients With Endogenous CS to Document Safety and Effectiveness of Ketoconazole"},{"key":"B143","unstructured":"Mitotane\n          \n          2015"},{"key":"B144","doi-asserted-by":"crossref","unstructured":"Pasireotide\n          \n          2017","DOI":"10.1530\/EDM-17-0003"},{"key":"B145","unstructured":"Cabergoline 0.5mg\n          \n          2023"},{"key":"B146","unstructured":"Etomidate\n          \n          2014"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.2147\/RMHP.S327440","article-title":"Cortisol in peripheral blood predicts the severity and prognosis in patients with liver failure at 90 days","volume":"14","author":"Zhang","year":"2021","journal-title":"Risk Manag Healthc Policy"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvac115","article-title":"Adrenal insufficiency in cirrhosis","volume":"6","author":"Wentworth","year":"2022","journal-title":"J Endocr Soc"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1111\/j.1699-0463.1960.tb04760.x","article-title":"The effect of ACTH on dehydrogenase activity following liver injury in mice. I. The effect of ACTH on the liver of controls","volume":"48","author":"Myren","year":"1960","journal-title":"Acta Pathol Microbiol Scand"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2006.02466.x","article-title":"Associations between liver histology and cortisol secretion in subjects with nonalcoholic fatty liver disease","volume":"64","author":"Targher","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2005.01583.x","article-title":"Relationship of non-alcoholic hepatic steatosis to cortisol secretion in diet-controlled Type 2 diabetic patients","volume":"22","author":"Targher","year":"2005","journal-title":"Diabetes Med"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2004.02154.x","article-title":"Relationship of nonalcoholic hepatic steatosis to overnight low-dose dexamethasone suppression test in obese individuals","volume":"61","author":"Zoppini","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1389982","article-title":"Influence of plasma cortisol and other laboratory parameters on nonalcoholic Fatty liver disease","volume":"47","author":"Hubel","year":"2015","journal-title":"Horm Metab Res"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14646","article-title":"Inhibition of 11\u03b2-Hydroxysteroid dehydrogenase-1 with AZD4017 in patients with nonalcoholic steatohepatitis or nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled, phase II study","volume":"24","author":"Yadav","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(13)70170-0","article-title":"Inhibition of 11\u03b2-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial","volume":"2","author":"Stefan","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.26.14924","article-title":"11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress","volume":"94","author":"Kotelevtsev","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.2337\/db14-0249","article-title":"5\u03b1-Reductase type 1 deficiency or inhibition predisposes to insulin resistance, hepatic steatosis, and liver fibrosis in rodents","volume":"64","author":"Livingstone","year":"2015","journal-title":"Diabetes"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2011.02685.x","article-title":"Overexpression of 11\u03b2-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue and portal hypercortisolism in non-alcoholic fatty liver disease","volume":"32","author":"Candia","year":"2012","journal-title":"Liver Int"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0305524101","article-title":"Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice","volume":"101","author":"Paterson","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1210\/en.2013-1592","article-title":"Loss of 5\u03b1-reductase type 1 accelerates the development of hepatic steatosis but protects against hepatocellular carcinoma in male mice","volume":"154","author":"Dowman","year":"2013","journal-title":"Endocrinology"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2008.03358.x","article-title":"Hepatic 11beta-HSD1 mRNA expression in fatty liver and nonalcoholic steatohepatitis","volume":"70","author":"Konopelska","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B162","doi-asserted-by":"publisher","first-page":"e29531","DOI":"10.1371\/journal.pone.0029531","article-title":"A switch in hepatic cortisol metabolism across the spectrum of nonalcoholic fatty liver disease","volume":"7","author":"Ahmed","year":"2012","journal-title":"PloS One"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1660316\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T04:14:16Z","timestamp":1761279256000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1660316\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":162,"alternative-id":["10.3389\/fendo.2025.1660316"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1660316","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"article-number":"1660316"}}